Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Correct me if I am wrong but were they not acquired by Valeant for 495 million?
A third of that volume was between .08 and .12
They traded from .011 up to .12. Where did you see sub .01?
Over 100,000 warrants traded
Over 80,000 traded.
Warrant volume is extremely high. MM's moved the bid/ask down 10 cents on no change in stock price about hour ago.
12-15 months is assuming it does not happen prior to March in 2018. Also, didn't Lombardo specifically state on the webcast that the manufacturing facilities were ready? I may have heard wrong.
Did anyone really expect any sort of significant decline in the short interest? Adxs short interest has remained at or near 10 million shares since prior to the AMGN deal. Please correct me if I am wrong?? If this is HFT manipulation I do not expect to see a decline in the short interest due to the fact they are colluding to short and cover on the way down leaving the short interest net the same. What will tell you if this is real selling is the institutional ownership when it comes out. Bottom line something is happening. It's either being manipulated down due to impending good news or someone knows bad new is coming.
PETX
Just an observation not making any sort of call. PETX has been slowly moving back up. ADXS has been very quiet of late regarding the expected conditional approval of AT-014 before year end. Understanding the revenue from this license is not significant, it does change the status of the company. ADXS would now have a licensed product generating revenue.
Meishairwin....with all due respect because I have always appreciated your contributions on this board as well as on IV. I fear that what truly did DOC in was the deal he did not due. Furthermore, in all fairness to Lombardo, he has inherited the current situation. I truly have no feel for whether or not he will be effective but I do believe he has to be given a chance. If anyone thought there was going to be some earth shattering revelation today their expectations were misguided.
No question this stock has been manipulated but looking at the chart the only other attack that had this kind of velocity was the one that coincided with the Pearson hit piece in early 2015. The stock was taken down over six dollars in three days with even more volume. It then road the biotech run to over $20 in April.
52 Week low 2.55 on 8/21/17
Now look at the bid/ask
Anyone who questions the manipulation need only to look at the last ten minutes of trading. Chart is sideways and then nothing but downward pressure. I suppose it was a coincidence and that someone decided to dump hundreds of thousands of shares in the last minutes.
They are absolutely trapping the price. Just look at L2
A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
Did this say "Has results" yesterday? I was checking the Clinical Study's site yesterday and did not recall seeing that designation. I could be wrong though.
You have more tolerance than I do in refuting the misinformation and nonsense that gets communicated on this board. The people who are searching for a real understanding of why ADXS is lower need to understand the machinations of WS a little better. Keep up the good work!
That's why I said if you want an answer to the trading activity look at the 6/16 7.5 calls. At least some people understand.
If you are looking for answers to the trading activity....look at the 6/16/17 7.5 calls.
The problem is that some of you have an unrealistic expectation based on the run ADXS made in the spring and summer of 2015. Oh...where was the IBB then? I believe it hit 400. Have you ever heard of market cycles. HDWRSFT I remember reading your posts from the old YMB going back a couple of years. No one raved about this stock more then you. ADXS is in a much better place now then it was then. If your only measure of the success/strength of this company is the "ticker" price today.....well I suggest you have a paradigm shift.
Look at the volume of the IBB. Money has not flowed back into this sector. Not to mention an individual stock will have a greater variance in price then an ETF especially if it's the target of manipulation. But I'm sure you'll say ADXS is a target because of DOC. On paper the company is doing very well.
fbg0316-I have been invested in ADXS for a number of years and for a good portion of that time I have listened to your repetitive rant regarding DOC's leadership. To date this is the first time I have actually signed up for a message board because I cant tolerate reading anymore of your contradictory babble. For an early stage biotech company to be a success it not only requires strong science but intelligent leadership. Has our pipeline not moved along at a strong pace? Do we not have sufficient capital to fund the current pipeline and operations for a reasonable period of time? Do we not see strong institutional ownership? These are a few of the things you want to see in an early stage biotech company. It would appear your only argument is the share price. Look at the sector as a whole. Look at the anemic volume of the IBB and other sector specific indexes. Your incessant rambling regarding DOC's leadership only leads me to believe you either do not really know what you are talking about or that you are short this stock.